Skip to content
REPORT (2023/2147(DEC))

On discharge in respect of the implementation of the budget of the European Centre for Disease Prevention and Control for the financial year 2022

A-9-2024-0109

Committee on Budgetary Control · Rapporteur: Petri Sarvamaa

✦ In short · AI summary of this text, generated 25 Sept 2026

Written by a language model from the full text only; every figure comes from the text. The paragraph links open the paragraph a statement rests on — check the text itself before relying on it.

Parliament's committee report proposes granting discharge to the Director of the European Centre for Disease Prevention and Control for the 2022 budget and approving the closure of its accounts. It notes the Centre's 2022 budget of EUR 99 872 000, a 40,59 % decrease from 2021, and a qualified Court of Auditors opinion on payments because VAT was included as an eligible grant cost. It asks the Commission for resources to implement the Centre's revised mandate, and the Centre to report on postponed outputs, gender and geographical balance, and conflicts of interest. It calls for reduced duplication between the Centre and HERA, full transparency in publishing scientific studies, and key public health information in all official EU languages.

Committee position. The Committee on Budgetary Control proposes that Parliament grant discharge to the Centre's Director for the 2022 budget and approve the closure of its accounts, while setting out observations on budget management, performance, staff, conflicts of interest and internal control.

Key points

  1. Parliament grants the Director of the Centre discharge for the implementation of the Centre's 2022 budget.
  2. Parliament approves the closure of the Centre's accounts for the financial year 2022.
  3. The Centre's final 2022 budget was EUR 99 872 000, a decrease of 40,59 % from 2021 due to changes in HERA grants.
  4. The Court of Auditors gave a qualified opinion on payments because three of four audited grant agreements included VAT of EUR 0,6 million (8,1 %) as eligible costs, estimated at 2,8 % of 2022 payment appropriations.
  5. Budget implementation reached 98,86 % for commitments and 73,61 % for payments; the Centre delivered 89 % of planned outputs, with 8 % postponed and 3 % delayed or cancelled.
  6. Parliament calls on the Commission to give the Centre resources to meet Strategy 2021-2027 and its revised mandate under Regulation (EU) 2022/2370.
  7. The Centre handled COVID-19, Mpox and hepatitis of unknown origin in children in 2022, and supported five countries around Ukraine with technical and operational activities.
  8. Parliament asks the Centre to report on postponed outputs, geographical balance in senior and middle management, and the People Strategy.
  9. It notes concern at the lack of gender balance in senior and middle management (four of six men) and asks the Commission and member states to consider balance in management board appointments.
  10. Parliament calls for reduced duplication and a clear division of tasks between the Centre and HERA.
  11. It calls on the Centre to ensure full transparency in publishing scientific studies and to make key public health information available in all official EU languages.
  12. It welcomes the Centre's digitalisation, automation of four administrative processes, EMAS registration aim, and 86 % stakeholder satisfaction.

Who is affected

  • The European Centre for Disease Prevention and Control and its Director, who receive discharge and must act on the observations.
  • The Commission, asked to grant the Centre resources for its revised mandate.
  • Member states, asked to consider gender balance when nominating management board members.
  • The Centre's management board, advisory forum and external experts, who must submit annual declarations of interest.

Figures and deadlines

  • EUR 99 872 000 — the Centre's final budget for 2022.
  • 40,59 % — decrease in the Centre's 2022 budget compared to 2021.
  • EUR 7,9 million — total value of four grant agreements audited by the Court.
  • EUR 0,6 million (8,1 %) — VAT included as eligible costs in three audited grant agreements.
  • 2,8 % — estimated non-compliant expenditure as a share of 2022 payment appropriations.
  • 98,86 % and 73,61 % — 2022 commitment and payment execution rates.
  • 89 %, 8 % and 3 % — outputs delivered, postponed, and delayed or cancelled in 2022.
  • 86 % — overall stakeholder satisfaction with the Centre's work in 2022.

Legal basis: Article 319 of the Treaty on the Functioning of the European Union.